Covered recipient · General Payments record
ING I LAM
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2018–2023
$5,457.04
- Reported across 333 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.81 | 29 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.68 | 10 |
| Corium, Inc. | $64.79 | 4 |
| Alkermes, Inc. | $60.30 | 4 |
| Janssen Pharmaceuticals, Inc | $60.24 | 2 |
| Tris Pharma Inc | $56.24 | 3 |
| Lundbeck LLC | $36.33 | 2 |
| IRONSHORE PHARMACEUTICALS INC. | $23.40 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.02 | 1 |
| Supernus Pharmaceuticals, Inc. | $17.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.47 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719317 | CMS |
| ABBVIE INC. | $21.80 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719319 | CMS |
| ABBVIE INC. | $10.60 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719321 | CMS |
| ABBVIE INC. | $26.22 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719323 | CMS |
| ABBVIE INC. | $10.45 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719325 | CMS |
| ABBVIE INC. | $13.42 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719327 | CMS |
| ABBVIE INC. | $17.24 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719329 | CMS |
| ABBVIE INC. | $8.14 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719331 | CMS |
| ABBVIE INC. | $8.80 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719333 | CMS |
| ABBVIE INC. | $11.54 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 997719335 | CMS |
| Alkermes, Inc. | $15.90 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022856315 | CMS |
| Alkermes, Inc. | $14.25 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022856317 | CMS |
| Alkermes, Inc. | $15.90 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022856319 | CMS |
| Alkermes, Inc. | $14.25 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022856321 | CMS |
| Corium, LLC | $15.19 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978055525 | CMS |
| Corium, LLC | $21.41 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978055533 | CMS |
| Corium, LLC | $13.00 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978205745 | CMS |
| Corium, LLC | $15.19 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978205735 | CMS |
| Ironshore Pharmaceuticals Inc. | $23.40 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060503329 | CMS |
| Janssen Pharmaceuticals, Inc | $27.97 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988603593 | CMS |
| Janssen Pharmaceuticals, Inc | $32.27 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988603591 | CMS |
| Lundbeck LLC | $19.33 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032270337 | CMS |
| Lundbeck LLC | $17.00 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032270343 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.02 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014493723 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.91 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053275471 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.90 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055444537 | CMS |
| Tris Pharma Inc | $17.57 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059328475 | CMS |
| Tris Pharma Inc | $21.77 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059328491 | CMS |
| Tris Pharma Inc | $16.90 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059328515 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.